Wetenschappelijke publicaties van Bordet

A Computational Multinephron Model for Small-Scale Preclinical Renal Dosimetry in Radiopharmaceutical Therapy.

Andersson M, Goudin N, Pontoglio M, Reynaert N, Levillain H, Vargas CS

A Computational Multinephron Model for Small-Scale Preclinical Renal Dosimetry in Radiopharmaceutical Therapy.

SHIP2-PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma.

Ramos AR, Bregni G, Gillet N, Ando K, Bodart C, Vercauteren Drubbel A, Descampe L, Moresi F, Bisteau X, Verheye Q, Pirard S, Erneux C, Beck B

SHIP2-PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma.

Comparing [ 18F]FDG-positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial.

García-Mosquera JJ, Pérez-García JM, Ruiz-Borrego M, Stradella A, Bermejo B, Escrivá-de-Romaní S, Calvo Martínez L, Gebhart G, Kerrou K, Gion M, Antonarelli G, Santasusagna Canal S, Rodríguez-Morato J, Mina L, Sampayo-Cordero M, Llombart-Cussac A, Cortés J

Comparing [ 18F]FDG-positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial.

EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.

Menis J, Greiller L, Demontrond P, Monnet I, Novello S, Livi L, Young R, Decroisette C, Cloarec N, Robinet G, Schott R, Fayette J, Banna GL, De Marinis F, Califano R, Duchemann B, Luciani A, Colantonio I, Fournier B, Pretzenbacher Y, Caramella C, Silva M, Berghmans T, Dingemans AM, Bironzo P, Tugwood J, Zhou C, Hill S, Bradbury K, Morris K, Kilgour E, Dive C, Blackhall F, Besse B

EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

de Angelis M, Pellegrino F, Scilipoti P, Longoni M, Santangelo A, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Khan MS, Thurairaja R, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Ślusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Resca S, Beatrici E, De Groote R, Mottrie A, Necchi A, Montorsi F, Briganti A, Moschini M

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

Brunelli A, Hardavella G, Huber RM, Berghmans T, Frille A, Rodriguez M, Tietzova I, Depypere L, Asteggiano R, Batchelor T, Costantini A, De Ruysscher D, Durieux V, Faivre-Finn C, Ferguson MK, Langer D, Marczin N, Nagavci B, Novoa N, Pompili C, Rawlinson J, Snoeckx A, Tonia T, van Geffen WH, Williams C, Caruana EJ, Kabalak PA, Mansmann U, Fallet V, Kauffmann-Guerrero D, Paesmans M, Al Tawil A, Alhannoush N, Creamer AW, Kourouni I, Blum TG

European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

Brunelli A, Hardavella G, Huber RM, Berghmans T, Frille A, Rodriguez M, Tietzova I, Depypere L, Asteggiano R, Batchelor T, Costantini A, Ruysscher D, Durieux V, Faivre-Finn C, Ferguson MK, Langer D, Marczin N, Nagavci B, Novoa N, Pompili C, Rawlinson J, Snoeckx A, Tonia T, van Geffen WH, Williams C, Caruana EJ, Kabalak PA, Mansmann U, Fallet V, Kauffmann-Guerrero D, Paesmans M, Tawil AA, Alhannoush N, Creamer AW, Kourouni I, Blum TG

European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

[ 177Lu]Lu-PSMA SPECT/CT for early response assessment using quantitative RECIP 1.0.

Kassas M, Devriendt L, Manley M, Guiot T, Marin C, Danieli R, Taraji L, Kristanto P, Karfis I, Woff E, Flamen P, Artigas C

[ 177Lu]Lu-PSMA SPECT/CT for early response assessment using quantitative RECIP 1.0.

Kassas M, Devriendt L, Manley M, Guiot T, Marin C, Danieli R, Taraji L, Kristanto P, Karfis I, Woff E, Flamen P, Artigas C

[ 177Lu]Lu-PSMA SPECT/CT for early response assessment using quantitative RECIP 1.0.

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Bordet